Notable strengths of this study include our use of propensity matching for causal inference on real-world data, being among the first to report serial (i.e., daily) measurements of cardiovascular measures and health behaviors among GLP-1 RA users, and our use of wearable technology that has been validated against gold-standard electrocardiogram and polysomnography measures with a low degree of bias and low precision of errors (10, 11)
Given that most patients on the medication are under 50, the need for exercise and preserving muscle mass is essential to avoid becoming prone to injuries
Patients on Wegovy often lose up to 15% of their body weight over time, compared to around 8-10% with Ozempic
In order to validate our results that the pharmaceutical properties of peptide 1 can be improved by substituting amino acids with oligourea triads, we conducted a series of IPGTT studies on the three best hybrids 14 , 22 and 23 with peptide 1 as control (Fig
On average, patients using Wegovy or Ozempic see significant weight loss within a few months, especially when paired with lifestyle changes